Skip to main content
. Author manuscript; available in PMC: 2009 Sep 28.
Published in final edited form as: Endocrinol Metab Clin North Am. 2009 Mar;38(1):207–222. doi: 10.1016/j.ecl.2008.11.009

Fig.1.

Fig.1

Guidelines for managing lipid disorders and risk of cardiovascular disease in patients receiving antiretroviral therapy. (Modified from Dube MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis 2003;37:614; with permission.)